Moderna, Inc. (MRNA) is listed on NASDAQ in Biotech Stocks. It is $137.93, -3.39%, with a $55.1B market cap. RSI is 63.6, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 63.6 Near Overbought
Market Cap $55.1B
Volume 15.5M
Fundamentals — 10-Q Q2 2026
Revenue $534.0M
Net Income $-2.1B
EPS $-5.36
Gross Margin -96.3%
Operating Margin -412.5%
Net Margin -397.9%
Debt / Equity 0.1x
P/E Ratio -25.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Bancel Stephane | Chief Executive Officer | Sell | 499,246 | $57.52 | $28.7M | 2026 Aug 5 |
| Hoge Stephen | President | Sell | 53,336 | $67.60 | $3.6M | 2026 Jul 15 |
| Hoge Stephen | President | Sell | 53,336 | $51.37 | $2.7M | 2026 Jun 15 |
| Klinger Shannon Thyme | Chief Legal Officer | Sell | 3,471 | $50.00 | $173,550 | 2026 Jun 4 |
| Afeyan Noubar | Insider | Sell | 9,263 | $46.84 | $433,879 | 2026 May 21 |
| Hoge Stephen | President | Sell | 53,336 | $48.40 | $2.6M | 2026 May 15 |
| Hussain Abbas | Director | Sell | 5,682 | $46.63 | $264,952 | 2026 May 1 |
| Klinger Shannon Thyme | Chief Legal Officer | Sell | 13,885 | $52.29 | $726,047 | 2026 Mar 2 |
| Hoge Stephen | President | Sell | 160,009 | $48.84 | $7.8M | 2026 Feb 23 |
| Afeyan Noubar | Director | Sell | 23,853 | $29.49 | $703,425 | 2025 Dec 11 |
| Hussain Abbas | Director | Sell | 504 | $27.60 | $13,910 | 2025 Dec 9 |
| Hussain Abbas | Director | Sell | 312 | $28.00 | $8,736 | 2025 Jun 11 |
| Sagan Paul | Director | Buy | 31,620 | $31.76 | $1.0M | 2025 Mar 3 |
| Bancel Stephane | Chief Executive Officer | Buy | 160,314 | $31.22 | $5.0M | 2025 Mar 3 |
| Klinger Shannon Thyme | Chief Legal Officer | Sell | 529 | $44.68 | $23,636 | 2024 Dec 9 |
| Klinger Shannon Thyme | Chief Legal Officer | Sell | 112 | $43.30 | $4,850 | 2024 Dec 3 |
| Hoge Stephen | President | Sell | 314 | $43.30 | $13,596 | 2024 Dec 3 |
| Klinger Shannon Thyme | Chief Legal Officer | Sell | 1,418 | $42.79 | $60,676 | 2024 Nov 29 |
| Mock James M | Chief Financial Officer | Sell | 1,420 | $42.79 | $60,762 | 2024 Nov 29 |
| Hoge Stephen | President | Sell | 291 | $42.79 | $12,452 | 2024 Nov 29 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $208.02 | 55.9 | $44.6B |
| | $1,023.96 | 63.8 | -- |
| | $141.42 | 61.5 | $8.9B |
| | $102.12 | 51.7 | -- |
| | $134.97 | 69.6 | $10.2B |
| | $105.31 | 69.1 | $12.0B |
Take MRNA further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put MRNA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Moderna, Inc. next reports.
Set alerts on MRNA
Get notified when Moderna, Inc. hits your price targets or technical conditions are met.
Get Started Free